Cargando…

P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

Detalles Bibliográficos
Autores principales: Liu, Hui, Xia, Linghui, Weng, Jianyu, Zhang, Fengkui, He, Chuan, Gao, Sujun, Jia, Jinsong, Chang, Alice, LI, Wenjin, Sreckovic, Sasha, Shi, Dayu, Zhang, Zilu, Fu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430678/
http://dx.doi.org/10.1097/01.HS9.0000970044.12879.03
_version_ 1785091024090038272
author Liu, Hui
Xia, Linghui
Weng, Jianyu
Zhang, Fengkui
He, Chuan
Gao, Sujun
Jia, Jinsong
Chang, Alice
LI, Wenjin
Sreckovic, Sasha
Shi, Dayu
Zhang, Zilu
Fu, Rong
author_facet Liu, Hui
Xia, Linghui
Weng, Jianyu
Zhang, Fengkui
He, Chuan
Gao, Sujun
Jia, Jinsong
Chang, Alice
LI, Wenjin
Sreckovic, Sasha
Shi, Dayu
Zhang, Zilu
Fu, Rong
author_sort Liu, Hui
collection PubMed
description
format Online
Article
Text
id pubmed-10430678
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104306782023-08-17 P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) Liu, Hui Xia, Linghui Weng, Jianyu Zhang, Fengkui He, Chuan Gao, Sujun Jia, Jinsong Chang, Alice LI, Wenjin Sreckovic, Sasha Shi, Dayu Zhang, Zilu Fu, Rong Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430678/ http://dx.doi.org/10.1097/01.HS9.0000970044.12879.03 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Liu, Hui
Xia, Linghui
Weng, Jianyu
Zhang, Fengkui
He, Chuan
Gao, Sujun
Jia, Jinsong
Chang, Alice
LI, Wenjin
Sreckovic, Sasha
Shi, Dayu
Zhang, Zilu
Fu, Rong
P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
title P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
title_full P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
title_fullStr P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
title_full_unstemmed P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
title_short P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
title_sort p785: six-month crovalimab extension in the phase 3 commodore 3 study: updated efficacy and safety results in complement inhibitor-naive patients (pts) with paroxysmal nocturnal hemoglobinuria (pnh)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430678/
http://dx.doi.org/10.1097/01.HS9.0000970044.12879.03
work_keys_str_mv AT liuhui p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT xialinghui p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT wengjianyu p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT zhangfengkui p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT hechuan p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT gaosujun p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT jiajinsong p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT changalice p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT liwenjin p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT sreckovicsasha p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT shidayu p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT zhangzilu p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh
AT furong p785sixmonthcrovalimabextensioninthephase3commodore3studyupdatedefficacyandsafetyresultsincomplementinhibitornaivepatientsptswithparoxysmalnocturnalhemoglobinuriapnh